Stifel Nicolaus analyst James Condulis maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $80.00. The company’s shares closed yesterday at $47.45.

Stifel Nicolaus analyst Adam Borg maintained a Buy rating on Autodesk (ADSK – Research Report) today and set a price target of $350.00. The company’s shares closed yesterday at $282.35.

Investing.com -- Stifel downgraded Vertex (NASDAQ:VRTX), Inc to “Hold” from “Buy” and lowered its price target to $31 from $35, over the company’s investment strategy and valuation.

Stifel's broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire business divisions; Keefe, Bruyette & ...

TFI International (NYSE:TFII – Free Report) had its price objective decreased by Stifel Nicolaus from $147.00 ... Public Employees Retirement System of Ohio acquired a new stake in shares ...

Insulet (NASDAQ:PODD – Get Free Report) had its price target hoisted by equities research analysts at Stifel Nicolaus from $245.00 to $293.00 in a research note issued on Friday,Benzinga reports.

Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire & Co., LLC business divisions ...

What should I know about this firm? Stifel, Nicolaus & Co. Inc. offers investment advising services that let individuals choose the level of control they have over their portfolio. Everyday ...